3rd March.2015.Physiology module Dr Jalees Khalid Khan Pathology Deptt. KEMU. Lahore Upper respiratory tract infections are the most common human affliction. Major share of time lost from work and school. Most common cause of antibiotic abuse. Figure 21.1 • • • Generally limited to the upper respiratory tract Gram-positive bacteria (streptococci and staphylococci) very common Disease-causing bacteria are present as normal biota; can cause disease if their host becomes immunocompromised or if they are transferred to other hosts (Streptococcus pyogenes, Haemophilus influenza, Streptococcus pneumonia, Neisseria meningitides, Staphylococcus aureus) • Normal biota perform microbial antagonism • • • • Most common place for infectious agents to gain access to the body Upper respiratory tract: mouth, nose, nasal cavity, sinuses, pharynx, epiglottis, larynx Lower respiratory tract: trachea, bronchi, bronchioles, lungs, alveoli Defences Nasal hair Cilia Mucus Involuntary responses such as coughing, sneezing, and swallowing – Macrophages – Secretory IgA against specific pathogens – – – – Influenza Epiglottitis Sinusitis The Common Cold Diphtheria Nosocomial infections-indisciminate use of drugs by doctors and quacks. Drug resistance-causes Cell wall alteration, Plasmid, ESBL,Efflux pump etc Lysogenic strains MRSA and others Pandemics Epidemics Endemic Seasonal Age Worldwide - antigenic shift Local - antigenic drift Sporadic Winter months - abrupt Infection: children >adults Mortality: adults >children Virus replication: 24 - 72 hours Virus excretion: 3 - 7 days Antibodies to HA, NA subtypes S. pneumoniae H. influenzae S. aureus - Toxin Shock Syndrome Post influenza B Encephalopathy Hepatic dysfunction Elevate NH3, LFTs, CPK Children:Streptococcus pneumoniae ◦ Most common cause outside of neonatal period ◦ Nasopharyngeal colonization – 50% of kids ◦ >90 serotypes – majority of invasive disease caused by 10 serotypes ◦ Bacteremia in 25-30% of kids ◦ Gram stain – gram positive lancet shaped diplococci (“gram positive cocci in pairs”) Adults – lobar pneumonia Kids – lobar or bronchopneumonia Classically a lobar consolidation on CXR Raise suspicion of staph ◦ ◦ ◦ ◦ Pneumatoceles Pleural effusion Air fluid levels Necrosis Changes in alveolar epithelial-ciliated columnar to pseudostratified/columnar epithelium Inefficiency of cilia to expel the debris,contaminants,carbon etc inhaled from atmosphere Emphysema, COPD, Bronchiectasis,Carcinoma of lung Trivalent vaccine A/Beijing/262/95-like (H1N1) A/Sydney/5/97-like (H3N2) B/Harbin/07/94 Elderly (age>65) High-risk* Household contacts Health-care personnel Pregnant women after 14th week High-risk: institutionalized, chronic heart or lung disease, diabetes, renal dysfunction, immunosuppressed, children on aspirin Killed vaccines Live vaccines Live vaccines are long acting while short acting are killed vaccines Immunization ◦ Measles – Pneumonia is what they die of – often super-infection World-wide coverage rate – 76% in 2004 Still having 30-40 million cases a year ◦ HemophilusInfluenzae B – 2-3 million cases of severe disease a year In 2003, developed world coverage – 92% Developing world – 42% Least developed countries – 8% Timing: October Mid-November Duration of immunity: start 1-2 weeks end 4-6 months Prozone phenomenon Serum sickness Fever, lymphadenopathy Severe anaphylactic reation Defective vaccine production-NIH DPT-not properly killed *Viral culture – tissue culture *Fluorescent-labeled murine monoclonal Ab shell viral cell culture viral Ag *PCR *CF - at onset and 2 weeks 4-fold-rise in Ab titre Control of outbreaks in institutions Adjunct to late vaccination Immunodeficient - AIDS Vaccine contraindicated Home caregivers of high risk Epidemiology: ◦ most common in children 3-7 yrs. ◦ decreased incidence because of Hib conjugate vaccine-stable rate in adults Rate: ◦ 1 in 1000-2000 pediatric admissions ◦ 1 in 100,000 adult admissions Peritonsillar abscess ◦ sore throat, drooling, hoarseness, trismus, asymmetric tonsillar enlargement Epiglottitis ◦ Children: high fever, toxic, drooling, absence of cough ◦ Adult: severe sore throat, dyshagia, fever Infectious mononucleosis ◦ tonsillar enlargement, exudative tonsillitis, pharyngeal inflammation, lymphadenopathy, splenomegaly, maculopapular rashes, petechial anathema Parapharyngeal space infection ◦ neck swelling after a sore throat Haemophilus influenzae type b, S. pneumoniae, S. aureus, H. influenzae type non-b, H. parainfluenzae Inflammation and edema of the epiglottis, arytenoids, arytenoepiglottic folds, subglottic area Epiglottis pulled down into larynx and occludes the airway Visualization of epiglottis - “cherry red” Laternal neck x-rays: “thumb sign” WBC count > 15,000 left shift Blood cultures Prophylaxis: Rifampin - 20 mg/kg for 4 days All household contacts if children under 4 Daycare and nursery school contacts Patient before discharge *Viral URI, fever (50%), purulent nasal discharge, swelling, facial pain worse on percussion, headache, nasal obstruction, loss of smell *Children: facial pain, swelling, malodorous breath (50%), cough (80%), nasal discharge (76%), fever (63%), sore throat (23%) Nasal swabs not helpful Transillumination of maxillary and frontal sinuses Sinus x-rays: air-fluid level, complete opacity, mucosal thickening CT scan not indicated - unless chronic infection, immunocompromised, suspected intracranial or orbital complication Direct sinus aspiration Impaired mucociliary function Obstruction of sinus ostia Immune defects Increased risk of microbial invasion Children MICROBIAL AGENT (Bacteria) Streptococcus pneumoniae Haemophilus influenzae (nonencapsulated) S. pneumoniae and H. influenzae Anaerobes (Bacteroides, Fusobacterium, Peptostreptococcus, Veillonella) Staphylococcus aureus Streptococcus pyogenes Branhamella (Moraxella) catarrhalis Gram-negative bacteria Fugal causes in immunocompromised PREVALENCE MEAN (RANGE) Adults (%) 31 (20-35) 21 (6-26) 5 (1-9) 6 (0-10) (%) 36 23 --- 4 (0-8) 2 (1-3) 2 9 (0-24) -2 19 2 PREVALENCE MEAN (RANGE) Adults Children (%) (%) MICROBIAL AGENT Viruses Rhinovirus 15 Influenza virus 5 Parainfluenza virus 3 Adenovirus --2 -- 2 Complication Meningitis Osteomyelitis Epidural abscess Subdural empyema Cerebral abscess Venous sinus thrombosis death Cavernous sinus palsies Clinical Signs Headache, fever, stiff neck lethargy, rapid death Pott’s puffy tumor Headache, fever Headache, seizures hemiplegia, rapid death Convulsions, headache, personality change Picket-fence fever, rapid Orbital edema, ocular Virus type Andenoviruses Coronaviruses Influenza viruses Parainfluenza viruses Respiratory syncytial virus Rhinoviruses Enteroviruses Serotypes 41 2 3 4 1 100+ 60+ May-Aug Sept-Dec Rhinoviruses, Jan-Feb - Mar-Apr Enteroviruses Mycoplasma, Parainf. 1+2, RSV Adenoviruses, Influenza, Coronaviruses Parainf. 3, Rhinoviruses Direct contact with infected secretions Hand - to - hand Hand - to environmental surface - to hand Spread by aerosoles Complications:Bacterial superinfection ◦ Otitis media ◦ Sinusitis ◦ S. pneumoniae, H. influenzae, B. catarrhalis Guillain-Barre Syndrome Asthma attacks Aspirin - prolonged excretion of rhinoviruses, influenza virus Children - aspirin associated with Reye’s syndrome Prevention:Vaccines ◦ influenza A/B ◦ adenoviruses types 4,7 Intranasal interferon ◦ rhinoviruses ◦ nasal obstruction, bloody discharge